Nature reviews urology - volume 4 issue 6, june 2007
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Men with hypogonadism and those undergoing androgen deprivation treatments for prostate cancer are at an increased risk of developing osteoporosis. Bisphophonates are important in the
treatment of, and protection against, osteoporosis. This article discusses the use of different bisphosphonates in this patient population, including their mechanisms of action, efficacy and
safety.